Shield Therapeutics salutes year of material progress
Two key successes were the positive results of the AEGIS-H2H study (Ferracru vs Ferinject) and the FDA's approval of Accrufer
Company
Shield Therapeutics PLC
LON:STX
Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer ® /Feraccru ® (ferric maltol). The group has launched Accrufer® in the US and Feraccru ® is commercialized in the UK and European Union by Norgine B.V., who also have the marketing rights in Australia and New Zealand. Shield also has an exclusive license agreement with Beijing Aosaikang Pharmaceutical for the development and commercialization of Accrufer ® / Feraccru ® in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co in the Republic of Korea, and with KYE Pharmaceuticals in Canada.
173 stories · page 2 of 2
Shield Therapeutics ties up US$63mln deal for Feraccru in China
House broker finncap said it was a good deal especially considering that ASK has to fund a clinical trial in China.
Shield Therapeutics adopts Quoted Companies Alliance Corporate Governance Code
The QCA champions the interests of the 1,250 small- and medium-sized listed firms in the UK
Proactive snapshot: Collagen, Haydale Graphene, Arecor
A look at some of the top stories from the Proactive newswire on Tuesday
Shield Therapeutics to present phase IIIb study data to key opinion leaders
Principal investigator Dr Stefanie Howaldt, from the MVZ-Immunology Clinic in Hamburg, said: "This data shows that not only is Feraccru a real oral alternative to IV iron for these patients with iron deficiency anaemia, but that it can also
Shield Therapeutics hopes to have US commercial partner by the year-end; gaining traction for key product in Europe
The updates were provided alongside the company's interim results
Archive
Proactive news snapshot: Shield Therapeutics, Block Energy, AFC Energy...
A glance at some of the day's highlights from the Proactive Investors newswire
Shield Therapeutics adds two-thirds to its value after receiving US approval for flagship product
The Food & Drug Administration has given what’s called broad label approval to Feraccru, which will be marketed as Accrufer in America
Archive
FTSE 100 closes near flat as global markets appear uninspired
Footsie closed up nearly a point at 7,368, while mid-cap cousin FTSE 250 shed over 77 points at 19,172
Archive
Tesco’s first quarter set to face tough comparisons
Tesco, DS Smith and PZ Cussons are the standout names in Thursday's diary.
Archive
Proactive news snapshot: Argo Blockchain, Sareum Holdings, WideCells Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
EQTEC gives ground as it draws on its loan facility
A look at the day's major movers, including Carclo, Sareum, Karelian, Kier, Fulcrum, Microsaic, Dignity and Scapa
Shield Therapeutics to continue “robust” defence of IP as Teva appeals Feraccru ruling
The pharmaceutical firm said no date for the appeal hearing had yet been set but it believed the initial EPO decision in its favour would be upheld
Shield Therapeutics primed for a busy year
Here we take a look under the hood of Shield Therapeutics
Archive
Gresham shoots higher as contract wins make for “excellent start” to the year
A look at some of the biggest risers and fallers in London on Thursday
Archive
Proactive news snapshot: Haydale Graphene, Echo Energy, ValiRx, Personal Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Westminster Group, Tekcapital, Shield Therapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
KCOM rings up strong gains as the telecoms group agrees to £504mln cash takeover bid
Some of the main news-driven risers and fallers in London on Wednesday...
Shield Therapeutics wins extended approval for Feraccru in Switzerland
The company is encouraged by progress being made with regulatory authorities ahead of an expected decision from US regulators in late July
Archive
FTSE 100 closes in the red as resource stocks come off the boil
After hitting a six-month high on Tuesday afternoon, London's blue-chips took a step back on Wednesday
Archive
Stagecoach and Winkworth trade strongly, Lighthouse lit up on Quilter deal
Here's a look at Wednesday's big share price movers.
Archive
Proactive news snapshot: Chariot Oil & Gas, African Battery Metals, AdEPT Technology, Minds + Machines …
A glance at some of the day's highlights from the Proactive Investors newswire
Shield Therapeutics targeting more lucrative Feraccru out-licence deals in 2019
One deal covering Europe, Australia and New Zealand helped to significantly bump up Shield’s 2018 results and the plan is to sign more lucrative agreements covering China and the US
Archive
FTSE 100 finishes higher as Brexit rumblings continue
Footsie gained around 27 points at 7,418, while FTSE 250 added 234 points at 19,563
Archive
AA’s performance to be eyed on Wednesday for any signs of possible breakdown
Investors will be looking to see if the breakdown services firm can continue its recent run of good fortune
Archive
Proactive news snapshot: Iofina, Circassia Pharma, Directa Plus, Instem …
A glance at some of the day's highlights from the Proactive Investors newswire
Shield Therapeutics says European Patent Office decides in company’s favour in relation to a Feracru patent
The AIM-listed firm said that the decision, made by the EPO’s opposition division, related to patent #2 668 175, which covers a "Process for preparing an iron hydroxypyrone"
Archive
Proactive news snapshot: NetScientific, Capital Drilling, Horizonte Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
GAN trumpets winning of an industry award ... the shares fall
A look at the day's major movers, including Gulf Marine Services, Boxhill, Chesterfield Resources, Proton Power, Abcam, Tandem, Red Emperor and FFI
Archive
Proactive news snapshot: Shield Therapeutics, Plexus Holdings, 88 Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Shield Therapeutics’ Feraccru iron deficiency drug shows its mettle in head-to-head study
In the year-long phase IIIb study, Feraccru was shown to deliver “comparable” results to Ferinject, the current standard of care injection given to patients with iron deficiency
Archive
Proactive news snapshot: Shield Therapeutics, ANGLE, Westminster Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Shield Therapeutics' shares rise as it hails results of extended trial of Feraccru
The extended 52-week open-label trial showed increased haemoglobin levels
Archive
Proactive news snapshot: Primary Health Properties, Circassia Pharmaceuticals, Shield Therapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
AorTech in good heart
A look at the day's major movers, including Tri-Star Resources, Quixant, Metals Exploration, NCC Group, Primary Health Properties, MedicX Fund, Nautical Marine Services, Blue Star Capital and Gama Aviation.
Shield Therapeutics funded through to 2020
Shield expects the results from its head-to-head study on Feraccru this quarter and a decision by the FDA on US approval by the end of July
Archive
Proactive news snapshot: Block Energy, H&T Group, ClearStar …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: ECSC Group, Anglesey Mining, Sirius Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Trans-Siberian Gold announces record quarterly production
A look at the day's major movers, including IGas Energy, Egdon Resources, Mobile Streams, GYG Group, Dillistone, Connect Group and Non-Standard Finance
Shield Therapeutics appoints Karis as chairman
Karis has been on the board for three years already and chairs the remuneration committee
Archive
FTSE 100 finishes in red as China growth worries hit global equities
Top laggard on Footsie was oil services giant Wood Group, which shed 4.09% to 524.80p
Archive
Proactive news snapshot: accesso Technology, Braveheart Investment, Thor Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
VR Education zooms past price target after ENGAGE commercial release
A look at the day's major movers, featuring GAME, WANdisco, Mediazest, Purplebricks and Sports Direct
US FDA to make decision on Shield Therapeutics’ Feraccru drug by end of July
The US is a huge and potentially lucrative market that Shield is understandably keen to crack
Archive
Proactive news snapshot: Faron Pharma, Itaconix, Eco Atlantic Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Faron Pharmaceuticals, Diversified Gas & Oil, Mkango Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Interserve weak as Kier Group cash call comments spark concerns for constructors
A look at some of the London market's biggest risers and fallers on Monday
Shield Therapeutics' Feraccru to be considered for US market by the FDA
Feraccru already has EU approval while in Switzerland the drug can be used for iron deficiency anaemia in adults with inflammatory bowel disease
FTSE 100 clings on to triple-digit gain
The Footsie looked destined to finish well off the top but still sporting a handsome gain following a weekend of deals at the G20 and Opec meetings
Mission Marketing Group shares step up, United Carpets declines
A look at some of the biggest risers and fallers in the UK market on Wednesday
Investments and investor services
Midatech Pharma doubles as biotech stocks excited by sector takeover moves
A look at some of the biggest risers and fallers in London on Wednesday.
Zinc Media on the front foot after CEO and finance chief buy shares
A look at some of the top risers and fallers in London today
Investments and investor services
FTSE 100 closes in red amid trader tensions but Tesco soars
FTSE 100 closed in the red - down around nine points at 7,257
Archive
Tesco's results to be a "positive catalyst" for the share price
Updates are expected from Tesco, ASOS, PageGroup and McCarthy & Stone
Archive
Retailers and recruiters in focus as Tesco, ASOS, Hays and PageGroup report
The week ahead includes full-year results from Tesco and Saga, interims from ASOS, WH Smith and McCarthy & Stone, and trading updates from Robert Walters, Hays and PageGroup
Oilers 88 Energy Limited and Eland Oil & Gas gush higher after updates
A look at some of the highlight movers, up and down, on Friday in London
Investments and investor services
FTSE 100 closes firmly lower on chilly Wednesday with ITV the big switch-off
The Footsie may have mainly traded sideways throughout the day but there have been some notable movements among blue-chips.
Archive
Advertising key to ITV's latest results broadcast; Taylor Wimpey continues housebuilder updates
Day ahead includes full-year results from blue chips including broadcaster ITV PLC, housebuilder Taylor Wimpey PLC, motor insurer Admiral PLC, and mid cap estate agents Foxton's PLC
Shield Therapeutics slumps as flagship drug fails pivotal Phase III trial
Feraccru is already available to treat iron deficiency anaemia (IDA) in patients with irritable bowel disease, but Shield was trying to show that it is effective at treating IDA in people with chronic kidney disease as well
Kosmos Energy falls as tests at Requin Tigre-1 exploration well in Senegal fail to detect any hydrocarbons
A look at some of the London market's biggest risers and fallers on Monday
Archive
Kingisher can't afford another duff trading update
Trading can change as fast as the weather for a home improvements retailer; not many are expecting it to have changed for the better for Kingfisher
Shield Therapeutics to raise £12mln to fund further development and commercialisation of Feraccru
“These funds will enable us to reach and go beyond the upcoming key inflection points”
Archive
ASOS expected to post another set of strong results
Analysts aren’t forecasting any surprises when the popular online fashion retailer reports its interims on Tuesday
Archive
ASOS tipped to show strength
Week ahead: Asos, Panmure Gordon, Sprue Aegis, Electrocomponents
Feraccru approval caps ‘transformational’ year for Shield
The pharmaceutical firm achieved marketing authorisation for its iron deficiency anaemia treatment Feraccru in February